Skip to main content
Tech.euFundingExplorerBeta

Vicebio

Exited

Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections.

Vicebio is tracked in the Tech.eu funding database. Based in London, UK; active in Healthtech. Acquired by Sanofi in 2025. Data as of Nov 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Jul 2025
Value
€1.4B
Acquiror
Sanofi (France)

Similar companies

same sector, similar size

Global coverage: FundingData